T. gondii possesses effector proteins that act on host cells, which are capable of inducing the activation of the STAT3, STAT6, and NF-κB pathways (Hakimi et al., 2017), thus leading to the production of many cytokines and immunomodulatory molecules that may interfere in infection latency. The gene discussed is STAT3; the disease is infection.